Zyngenia's Series B Round

Zyngenia raised a round of funding on December 26, 2010. Investors include New Enterprise Associates.

Zyngenia is a biotherapeutics company focused on the development of the next-generation of antibody-derived drugs. The company enables the development of singular molecular entities that address two …

Articles about Zyngenia's Series B Round: